Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide mimics the action of endogenous incretins to enhance insulin secretion while suppressing glucagon levels, delaying gastric emptying, and reducing appetite.
The compound features a unique 39-amino acid peptide backbone with two non-natural residues (Aib at positions 2 and 13) and a C20 fatty diacid side chain at Lys20, contributing to its extended half-life of approximately 117 hours. These structural characteristics make tirzepatide particularly effective for sustained metabolic effects.
Available in various concentrations from 5mg to 60mg vials, our tirzepatide for sale meets strict pharmaceutical standards with 99% purity. The product is supplied as freeze-dried powder in sterile vials, suitable for research applications.
For research purposes, typical administration involves subcutaneous injection with dose escalation protocols. The compound has shown significant potential in clinical studies for both glycemic control and weight management applications.